Upload
mdconferencefindercom
View
171
Download
5
Embed Size (px)
Citation preview
The
Albe
rt J.
Fin
esto
ne, M
.D.
Offi
ce fo
r Con
tinui
ng M
edic
al E
duca
tion
Tem
ple
Uni
vers
ity S
choo
l of M
edic
ine
3440
N. B
road
Str
eet,
Kres
ge 1
00Ph
ilade
lphi
a, P
A 19
140
VIS
IT O
UR
WE
BSI
TE
ww
w.t
empl
e.ed
u/cm
e
Shar
e th
is b
roch
ure
wit
h
you
r co
lleag
ues
an
d o
ther
h
ealt
hca
re p
rofe
ssio
nal
s
NO
N-P
ROFI
T O
RG.
U.S.
PO
STAG
E
PAID
PERM
IT N
O. 2
26PH
ILAD
ELPH
IA, P
A
What Is NeW IN IdIoPathIc PulMoNary FIbrosIs?
2013
WedNesday, october 23, 20136:30-8:30 PM
locatIoN: thepalmrestaurant2801pacificavenue•atlanticcity,NJ08401
Guest sPeaKer: KevinBrown,mD,NationalJewishhealth,Denver,co
PreseNted by: templeUniversitySchoolofmedicine
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
taRget audience:Pulmonologists, Primary Care Physicians, Respiratory Therapists, Physician Assistants, Nurse Practitioners, and Nurses involved in the treatment of IPF
leaRning obJectives:After the completion of this activity, participants should be able to:
• Explain the role of evidence-based guidelines in the diagnosis of IPF
• Describe pharmacologic and non-pharmacologic approaches to treating IPF
• Discuss the importance of patient lifestyle management tools
• Discuss various health related quality of life (QOL) measures used in IPF clinical trials with respect to patient outcomes
accReditation statement:Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
ceRtiFication statement:Temple University School of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
disclosuRe policy:It is the policy of the Temple University School of Medicine, The Albert J. Finestone, M.D., Offi ce for Continuing Medical Education that the speaker and provider disclose real or apparent confl icts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Temple University School of Medicine, Offi ce for Continuing Medical Education has established policies in place that will identify and resolve all confl icts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity. WedNesday, october 23, 2013
2801pacificavenue•atlanticcity,NJ08401
2 AMA PRA Category 1 Credits™
RegistRation FoRm
What is neW in idiopathic pulmonaRy FibRosis?
RegistRation is FRee. seating is limited – RegistRation is RequiRed complimentaRy valet paRking
RetuRn to:Chris Rausch Office for Continuing Medical Education Temple University School of Medicine 3440 N. Broad Street, Kresge 100 Philadelphia, PA 19140 215-707-4787 or 800-23-TUCME or FAX 215-707-8268 Register online at www.temple.edu/cme
How did you hear about this program?
Name:
Degree:
Specialty:
aDDreSS:
city: State: Zip:
DaytimephoNe:
email:
If you have special needs that we can address to make your participation more meaningful and enjoyable, please contact our office at (215) 707-4787.
Faculty:
Kevin K. Brown, MDProfessor and Vice ChairmanDepartment of MedicineNational Jewish HealthDenver, CO
Gerard Criner, MDChair, Department of Medicine Professor of MedicineDirector, Division of Pulmonary and Critical Care MedicineTemple University School of Medicine
Irene Swift, MDAssistant Professor of MedicinePulmonary and Critical Care MedicineTemple University School of Medicine
Yoshiya Toyoda, MDProfessor of SurgeryCardiothoracic SurgeryTemple University School of Medicine
Michelle Vega-Olivo, MSN, CRNP, FNP-BCPulmonary Nurse PractitionerTemple Lung Center
pRogRam agenda:
6:15 – 6:25 PM Registration and Dinner
6:25 – 6:30 PM Introductory RemarksGerard Criner, MD
6:30 – 6:55 PM Diagnosing IPF Based on Evidence-Based Guidelines Irene Swift, MD
6:55 – 7:25 PM Pharmacologic and Non-Pharmacologic Approach to Treating IPF Kevin K. Brown, MD
7:25 – 7:45 PM Patient Lifestyle Management ToolsMichelle Vega-Olivo, MSN, CRNP, FNP-BC
7:45 – 8:15 PM Management of Advanced-Stage DiseaseYoshiya Toyoda, MD
8:15 – 8:30 PM Roundtable Discussion and Q&AGerard Criner, MD
8:30 PM Adjourn
What Is NeW IN IdIoPathIc PulMoNary FIbrosIs?
2013